Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes

被引:78
作者
Brachet, V
Raposo, G
Amigorena, S
Mellman, I
机构
[1] INSERM CJF 9501,SECT RECH,INST CURIE,F-75231 PARIS 05,FRANCE
[2] CNRS UMR 144,F-75231 PARIS 05,FRANCE
[3] YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06520
关键词
D O I
10.1083/jcb.137.1.51
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Major histocompatibility complex class II molecules are synthesized as a nonameric complex consisting of three ap dimers associated with a trimer of invariant (Ii) chains. After exiting the TGN, a targeting signal in the Ii chain cytoplasmic domain directs the complex to endosomes where Ii chain is proteolytically processed and removed, allowing class II molecules to bind antigenic peptides before reaching the cell surface. Ii chain dissociation and peptide binding are thought to occur in one or more postendosomal sites related either to endosomes (designated CIIV) or to lysosomes (designated MIIC). We now find that in addition to initially targeting crp dimers to endosomes, Ii chain regulates the subsequent transport of class II molecules. Under normal conditions, murine A20 B cells transport all of their newly synthesized class II I-Ab crp dimers to the plasma membrane with little if any reaching lysosomal compartments. Inhibition of Ii processing by the cysteine/serine protease inhibitor leupeptin, however, blocked transport to the cell surface and caused a dramatic but selective accumulation of I-A(b) class II molecules in lysosomes. In leupeptin, I-A(b) dimers formed stable complexes with a 10-kD NH2-terminal Ii chain fragment (Ii-p10), normally a transient intermediate in Ii chain processing, Upon removal of leupeptin, Ii-p10 was degraded and released, I-A(b) dimers bound antigenic peptides, and the peptide-loaded dimers were transported slowly from lysosomes to the plasma membrane, Our results suggest that alterations in the rate or efficiency of Ii chain processing can alter the postendosomal sorting of class II molecules, resulting in the increased accumulation of alpha beta dimers in lysosome-like MIIC. Thus, simple differences in Ii chain processing may account for the highly variable amounts of class II found in lysosomal compartments of different cell types or at different developmental stages.
引用
收藏
页码:51 / 65
页数:15
相关论文
共 57 条
[1]   INVARIANT CHAIN CLEAVAGE AND PEPTIDE LOADING IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II VESICLES [J].
AMIGORENA, S ;
WEBSTER, P ;
DRAKE, J ;
NEWCOMB, J ;
CRESSWELL, P ;
MELLMAN, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1729-1741
[2]   TRANSIENT ACCUMULATION OF NEW CLASS-II MHC MOLECULES IN A NOVEL ENDOCYTIC COMPARTMENT IN B-LYMPHOCYTES [J].
AMIGORENA, S ;
DRAKE, JR ;
WEBSTER, P ;
MELLMAN, I .
NATURE, 1994, 369 (6476) :113-120
[3]   EFFICIENT ENDOSOMAL LOCALIZATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-INVARIANT CHAIN COMPLEXES REQUIRES MULTIMERIZATION OF THE INVARIANT CHAIN TARGETING SEQUENCE [J].
ARNESON, LS ;
MILLER, J .
JOURNAL OF CELL BIOLOGY, 1995, 129 (05) :1217-1228
[4]   MHC CLASS-II-ASSOCIATED INVARIANT CHAIN CONTAINS A SORTING SIGNAL FOR ENDOSOMAL COMPARTMENTS [J].
BAKKE, O ;
DOBBERSTEIN, B .
CELL, 1990, 63 (04) :707-716
[5]   DETECTION OF FUNCTIONAL CLASS II-ASSOCIATED ANTIGEN - ROLE OF A LOW-DENSITY ENDOSOMAL COMPARTMENT IN ANTIGEN-PROCESSING [J].
BARNES, KA ;
MITCHELL, RN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1715-1727
[6]   HOW MHC CLASS-II MOLECULES REACH THE ENDOCYTIC PATHWAY [J].
BENAROCH, P ;
YILLA, M ;
RAPOSO, G ;
ITO, K ;
MIWA, K ;
GEUZE, HJ ;
PLOEGH, HL .
EMBO JOURNAL, 1995, 14 (01) :37-49
[7]  
BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488
[8]   ROLE FOR INTRACELLULAR PROTEASES IN THE PROCESSING AND TRANSPORT OF CLASS-II HLA ANTIGENS [J].
BLUM, JS ;
CRESSWELL, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (11) :3975-3979
[9]   ROLE OF B-CELL RECEPTOR IG-ALPHA AND IG-BETA SUBUNITS IN MHC CLASS II-RESTRICTED ANTIGEN PRESENTATION [J].
BONNEROT, C ;
LANKAR, D ;
HANAU, D ;
SPEHNER, D ;
DAVOUST, J ;
SALAMERO, J ;
FRIDMAN, WH .
IMMUNITY, 1995, 3 (03) :335-347
[10]  
BRAUNSTEIN NS, 1990, J IMMUNOL, V145, P1635